Lv5
990 积分 2025-08-21 加入
Type 2 diabetes: summary of updated NICE guidance
12天前
已完结
Particulate matter of air pollution may increase risk of kidney failure in IgA nephropathy
17天前
已完结
Aldosterone and Treatment-Resistant Hypertension
18天前
已完结
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
19天前
已完结
Asian Expert Consensus on Nocturnal Hypertension Management
19天前
已完结
Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes
19天前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
23天前
已完结
Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial
24天前
已完结
Semaglutide administration protects cardiomyocytes in db/db mice via energetic improvement and mitochondrial quality control
26天前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
26天前
已完结
皖公网安备34019202002308
